• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRIâ„¢ Website
      • ISPRI Downselectâ„¢
      • ISPRI Quantifyâ„¢
      • ISPRI Analyzeâ„¢
      • ISPRI Evaluateâ„¢
      • ISPRI-HCPâ„¢
      • ISPRI Designâ„¢
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAXâ„¢
      • EpiCCâ„¢
      • Ancer®
      • PreVAXâ„¢
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
    • Blog
  • Contact Us
Most Recent Publications
In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies

04-2024

Neoadjuvant personalized cancer vaccines: the final frontier?

01-2024

Poster: T cell Epitope Content Comparison (EpiCC) of swine H1 influenza A virus hemagglutinin to identify best vaccine match

01-2024

A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses

11-2023

Development of IFNβ-1a versions with reduced immunogenicity and full in vitro biological activity for the treatment of multiple sclerosis

11-2023

Poster: In silico immunogenicity risk assessment for fusion proteins and novel antibody modalities

11-2023

Does human homology reduce the potential immunogenicity of non-antibody scaffolds?

10-2023

Poster: iVAX for antigen discovery, vaccine design, diagnostics, and epidemiology

09-2023

Poster: Prospectively Assessing the Immunogenic Risk of Potential Synthetic Peptide Impurities in silico with the What-if Machine (WhIM)

09-2023

Prospectively Assessing the Immunogenic Risk of...

Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics

09-2023

Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning

09-2023

Identification of immunodominant T cell epitopes induced by natural Zika virus infection

08-2023

« Older Entries
Next Entries »

Join our newsletter

Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CMO, Dr. Annie De Groot.

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.